They observed that the downregulation of DNMT1 or the upregulation of miR‐152‐3p resulted in a decrease in TMSB10 expression, thereby exerting inhibitory effects on the progression of CRC and the growth of tumours. This evidence concerns the gene TMSB10 and colorectal carcinoma.